Primo Chemicals Ltd Upgraded to Hold as Technicals and Financials Improve

Technical Trend Shift Spurs Upgrade

The primary catalyst for the upgrade was a marked improvement in Primo Chemicals’ technical grade, which moved from mildly bearish to mildly bullish. Key technical indicators underpinning this shift include a bullish MACD on the weekly chart and mildly bullish readings on the monthly chart. Bollinger Bands also reflect a bullish stance on both weekly and monthly timeframes, suggesting increased momentum and potential for upward price movement.

Other technical signals such as the KST (Know Sure Thing) indicator have turned bullish weekly and mildly bullish monthly, reinforcing the positive trend. While the daily moving averages remain mildly bearish, the weekly Dow Theory signals a mildly bullish trend, indicating that the medium-term outlook is improving despite some short-term caution. The Relative Strength Index (RSI) and On-Balance Volume (OBV) remain neutral, showing no strong overbought or oversold conditions and a lack of significant volume trend, respectively.

This technical improvement is reflected in the stock’s recent price action, with the current price at ₹26.36, up from the previous close of ₹22.02, marking a substantial day change of 19.71%. The stock has also outperformed the Sensex over multiple periods, delivering a 13.92% return over the past week compared to the Sensex’s decline of 0.71%, and a 10.06% year-to-date gain versus the Sensex’s negative 12.88% return.

Valuation Adjusted from Attractive to Fair

Alongside technical improvements, Primo Chemicals’ valuation grade was revised from attractive to fair. The company currently trades at a price-to-earnings (PE) ratio of 41.07, which, while elevated, is more reasonable relative to its peers in the commodity chemicals sector. For context, competitors such as Stallion India and Sanstar carry PE ratios of 50.05 and 62.77 respectively, with some like I G Petrochems trading at extremely high multiples above 600.

Other valuation metrics include an EV to EBITDA ratio of 11.22 and an EV to Capital Employed of 1.44, both indicating a moderate premium but not excessive overvaluation. The PEG ratio stands at a low 0.12, signalling that earnings growth is not fully priced in, which could be a positive sign for investors seeking growth potential. However, the company’s return on capital employed (ROCE) is modest at 2.95%, and return on equity (ROE) is similarly low at 3.83%, reflecting limited profitability despite recent improvements.

Primo Chemicals’ valuation is thus fair rather than cheap, reflecting a balance between growth prospects and current earnings performance. This re-rating aligns with the company’s improved financial results and technical outlook, suggesting a more balanced risk-reward profile for investors.

Financial Trend Shows Strong Recent Growth

Financially, Primo Chemicals has demonstrated a significant turnaround in recent quarters. The company’s profit after tax (PAT) for the latest six months reached ₹7.11 crores, representing a remarkable growth of 278.38%. Profit before tax excluding other income (PBT less OI) for the quarter stood at ₹2.16 crores, an extraordinary increase of 1083.6% compared to the previous four-quarter average.

Additionally, the company’s debt-equity ratio has improved to a low 0.32 times as of the half-year mark, indicating a conservative capital structure and reduced financial risk. Despite these positive trends, the company’s long-term operating profit growth remains a concern, having declined at an annualised rate of 30.88% over the past five years. This mixed financial picture underpins the Hold rating, reflecting cautious optimism tempered by historical challenges.

Over the past year, Primo Chemicals’ stock has delivered a 5.23% return, outperforming the Sensex’s negative 8.84% return. Profit growth over the same period has been robust at 336.8%, further supporting the revised rating. However, the company remains a micro-cap with a market capitalisation grade reflecting its smaller size and associated liquidity considerations.

Quality Assessment and Shareholder Structure

In terms of quality, Primo Chemicals maintains a moderate Mojo Score of 61.0, which corresponds to a Hold grade. This score reflects a balanced assessment of the company’s operational and financial health, with neither strong nor weak signals dominating. The company is part of the commodity chemicals industry and sector, which is subject to cyclical demand and pricing pressures.

Majority shareholding remains with non-institutional investors, which may impact liquidity and volatility. The stock’s 52-week price range is ₹16.21 to ₹31.44, with the current price near the upper end, indicating recent strength but also limited upside from the peak.

Technical Outlook and Market Performance

From a technical perspective, the upgrade to a mildly bullish trend is significant for a micro-cap stock like Primo Chemicals. The weekly MACD and Bollinger Bands suggest momentum is building, while the monthly indicators confirm a stabilising uptrend. The stock’s recent price surge to ₹26.36, close to its 52-week high of ₹31.44, reflects growing investor confidence.

Comparatively, the stock has outperformed the Sensex across multiple time horizons, including a staggering 819.11% return over ten years versus the Sensex’s 176.58%. However, the three-year return remains negative at -59.63%, highlighting volatility and cyclical challenges in the medium term.

Investors should note that while the technical signals are encouraging, the daily moving averages remain mildly bearish, suggesting some short-term caution. The absence of strong volume trends (neutral OBV) means that confirmation of sustained buying interest is still awaited.

Valuation in Context of Peers

When benchmarked against peers, Primo Chemicals’ valuation appears reasonable. While it trades at a PE of 41.07, this is lower than several sector peers such as Stallion India (PE 50.05) and Sanstar (PE 62.77). Its EV to EBITDA ratio of 11.22 is also more moderate compared to others like Sanstar at 53.68 and Titan Biotech at 47.43.

The company’s PEG ratio of 0.12 is particularly attractive, indicating that earnings growth is not fully reflected in the price. This contrasts with some peers that have PEG ratios above 1 or are not meaningful due to zero or negative earnings growth. However, the relatively low ROCE and ROE suggest that profitability improvements are still needed to justify higher valuations.

Conclusion: A Balanced Hold Recommendation

Primo Chemicals Ltd’s upgrade from Sell to Hold is driven by a combination of improved technical indicators, fairer valuation, and strong recent financial performance. The stock’s outperformance relative to the Sensex and peers, alongside a significant surge in profits and reduced leverage, supports a more positive outlook.

Nonetheless, the company’s modest profitability metrics and poor long-term operating profit growth warrant caution. The Hold rating reflects this balanced view, suggesting that while the stock is no longer a sell, investors should monitor ongoing financial trends and technical signals closely before committing further capital.

Given its micro-cap status and sector cyclicality, Primo Chemicals remains a stock for investors with a higher risk tolerance and a focus on medium-term recovery potential rather than immediate gains.

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →